In childhood cancer survivors, GH therapy improves height without secondary tumor risk

In childhood cancer survivors, treatment with growth hormone was associated with gains in height vs. untreated control patients without increased risk for diabetes or secondary tumors, according to a meta-analysis published in The Journal of Clinical Endocrinology & Metabolism.

Read more: https://www.healio.com/endocrinology/hormone-therapy/news/in-the-journals/%7B117d22b3-0763-4c1b-8591-028e820ac433%7D/in-childhood-cancer-survivors-gh-therapy-improves-height-without-secondary-tumor-risk